Top 100 drugs Flashcards
(441 cards)
What are Dipeptidylpeptidase-4 inhibitors indicated for?
Type 2 Diabetes: In combination with metformin (or other hyperglycaemic agents) where blood glucose is inadequately controlled.
As a single agent where metformin is contraindicated or not tolerated.
What is the mechanism of action for DPP-4 inhibitors?
Incretins and glucose-dependent insulinotropic peptide are released by the intestine throughout the day, and particularly in response to food - these promote the secretion of insulin and suppress glucagon release, thus lowering blood glucose. Incretins are rapidly inactivated by the enzyme DPP-4. DPP-4 inhibitors therefore prevent the degradation of incretins and increase plasma concentrations of their active forms, lowering blood glucose concentrations.
Which are less likely to cause HYPOglycaemia, DPP-4 inhibitors or sulphonylureas ?
DPP-4 inhibitors - As the action of incretins are glucose dependent they do not stimulate the secretion of insulin at normal blood glucose levels or suppress glucagon release in response to hypoglycaemia. This means DPP-4 inhibitors are less likely to cause hypoglycaemia than sulphonylureas which stimulate insulin secretion irrespective of blood glucose.
Name the DDP-4 inhibitors
Alogliptin, Sitagliptin, Linagliptin and Saxagliptin
What are the potential adverse effects associated with the use of DPP-4 inhibitors?
- HYPOglycaemia where DPP-4 inhibitors are being used in combination with sulphonylureas and/or insulin
- All DPP-4 inhibitors are associated with acute pancreatitis which typically presents as persistent abdominal pain resolved upon stopping of the drug
- GI upset
- Headache
- Nasopharyngitis
- Peripheral oedema
Can DPP-4 inhibitors be used to treat Type 1 diabetes?
No
Can DPP-4 inhibitors be used to treat ketoacidosis?
No
Can DPP-4 inhibitors be used during pregnancy or breastfeeding?
No
How are DPP-4 inhibitors excreted?
Renally
When should DPP-4s be dose adjusted?
During moderate to severe renal impairment
When are DPP-4 inhibitors contraindicated?
DPP-4 inhibitors are contraindicated in patients with hypersensitivity to the drug class
When should DPP-4 inhibitors be used with caution?
- Elderly (>80 years)
- History of pancreatitis
Use of which other drug classes increases the risk of HYPOglycaemia in concurrent use with DPP-4 inhibitors?
- Sulphonylureas
- Insulin
- Alcohol
Which drug class may mask the symptoms of HYPOglycaemia?
Beta-blockers
What is the typical dosing of DPP-4 inhibitors?
Once daily
What quantity of the the daily dose of a DPP-4 inhibitor dose a combined formulation with metformin contain?
Half the daily dose
What is the key counselling point when advising a patient on the use of a DPP-4 inhibitor?
Acute Pancreatitis - seek medical attention if you develop severe or acute stomach pain radiating to the back
Which indicator is used to assess glycaemic control when using a DPP-4 inhibitor?
HbA1c
What are the target HbA1c levels for monotherapy and combined therapy with a DPP-4 inhibitor?
Monotherapy - <48mmol/mol
Combination therapy - <53mmol/mol
What HBA1c is generally a trigger to intensify treatment with an additional agent when using a formulation of a DPP-4 inhibitor?
> 58mmol/mol
What advantage do metformin and SGLT2 inhibitors have over use of DPP-4 inhibitors?
They reduce the risk of vascular complications
The efficacy of DPP-4 inhibitors is reduced by which medications that elevate levels of blood glucose?
- Prednisolone
- Thiazide
- Loop diuretics
What is the indication for metformin?
Type 2 diabetes as a a monotherapy or in combination with DPP-4 inhibitors, Sulphonylureas, or insulin
What is the mechanism of action for metformin?
Metformin (a biguanide) lowers blood glucose by reducing hepatic glucose output (glycogenolysis and gluconeogenesis)) and to a lesser extend increasing the uptake and utilisation of glucose by skeletal muscle. Metformin achieves its mechanism of action through activation of AMP (adenosine monophosphate- activated) kinase which acts as a metabolic sensor.